Exposure assessment analyses conducted in Europe have concluded that the primary pathway of exposure to di(2-ethylhexyl) phthalate (DEHP) is through the diet. The purpose of this study is to evaluate whether urinary DEHP metabolite data from the 2007-2008 National Health and Nutritional Examination Survey (NHANES) demonstrate relationships with reported food-fasting time consistent with diet as the predominant exposure pathway. Previous controlled-dosing data demonstrate that DEHP metabolite concentrations in urine first rise and then decline over time, with first-order elimination becoming evident at about 6 h post exposure. Regression of the concentrations of four key DEHP metabolites vs reported fasting times between 6 and 18 h in adults resulted in apparent population-based urinary elimination half-lives, consistent with those previously determined in a controlled-dosing experiment, supporting the importance of the dietary pathway for DEHP. For fasting times less than about 6 h, sampling session (morning, afternoon, or evening) affected the measured metabolite concentrations. Evening samples showed the highest metabolite concentrations, supporting a hypothesis of recent daily dietary exposures from multiple meals, whereas morning and afternoon samples for fasting times less than 6 h were similar and somewhat lower than evening samples, consistent with less-substantial early day dietary exposure. Variations in children's bodyweightnormalized creatinine excretion and food intake rates contribute to a strong inverse relationship between urinary DEHP metabolite concentrations and age under age 18. Finally, a previously published pharmacokinetic model for DEHP demonstrates that time since previous urinary void, a parameter not measured in NHANES, is predicted to result in non-random effects on measured urinary concentrations.
Introduction
Evidence has been developed in several studies, suggesting that dietary exposures predominate for di(2-ethylhexyl) phthalate (DEHP). Direct exposure assessments combine data on concentrations of phthalates in exposure media with contact factors to estimate total exposures. Wormuth et al. (2006) conducted such a study looking at European exposures to several phthalates. With albeit limited data on phthalate concentrations in exposure media (including some data from North America and Asia), they concluded that DEHP exposure was dominated by diet, with median and upper bound intakes for Europeans of approximately 2 and 15 mg/kg/day, respectively. They found that whereas exposures to di-isobutyl phthalate (DiBP), di-n-butyl phthalate (DnBP), and benzylbutyl phthalateBzBP were substantially influenced by dietary exposure, exposures to lower molecular weight phthalates including dimethyl and diethyl phthalates were more heavily influenced by dermal and inhalation exposures from personal care products. Similar exposure assessments were conducted by Clark et al. (2003 Clark et al. ( , 2011 , and they also concluded that DEHP exposures in the United States were diet driven, with estimated intakes for adults in the range of 8-11 mg/kg/day.
Experimental studies provide more definitive evidence of the importance of dietary exposures for DEHP. Wittassek et al. (2011) measured urinary phthalate metabolite concentrations in three individuals who fasted for 2 days on only bottled water. DEHP metabolites declined to trace levels after about 14 h, and stayed at low levels throughout the fast for all individuals. In contrast, metabolites from other phthalates including DnBP, DiBP, and BzBP first showed some decline, but then rose during the second day of fasting, suggesting that exposures were occurring by non-dietary routes. Fromme et al. (2007) conducted a duplicate diet study, in which food composites from the actual diets of 50 individuals were obtained, and then measured for DEHP, DnBP, and DiBP. Concurrently, all urine voids for a week were collected and measured for the phthalate monoester metabolites. The authors estimated intake from the 24-h urinary concentration normalized to creatinine excretion in conjunction with previously estimated urinary excretion fractions, and compared the estimated intakes with those calculated from food concentrations and consumptions. The DEHP intakes calculated both ways tracked very well, showing the importance of dietary pathways for this phthalate, whereas total intakes inferred from urine concentrations were higher than estimated from diet for other phthalates, showing that other pathways of exposure were important.
The purpose of this study is to evaluate whether evidence for the importance of dietary pathway for DEHP can be found in data from the National Health and Nutritional Examination Survey, NHANES, conducted by the Centers for Disease Control (CDC) in the United States. NHANES is a program of studies designed to assess the health and nutritional status of adults and children in the United States, and includes measures of chemical exposures via biomonitoring on a recurring basis. Some participants are instructed to fast before providing a urine and blood sample, although this practice has changed over time, and participants provide information on time of last consumption of food. On the basis of rapid elimination of DEHP metabolites in urine (with half-lives on the order of 5 to 15 h, Koch et al., 2005) , it can be hypothesized that, assuming the dietary pathway predominates for DEHP, urinary concentrations of DEHP metabolites should decline with increasing time since last reported food consumption after an initial absorption period. The hypothesis evaluated here is that if the primary route of exposure to DEHP is dietary, independent of other variables, the trends in concentrations of DEHP metabolites in relationship to time since last food exposure should parallel the urinary elimination pharmacokinetics reported by Koch et al. (2005) .
The same hypothesis was tested for bisphenol A (BPA) exposures in a similarly designed analysis of NHANES by Stahlhut et al. (2009) . Similar to DEHP, external evidence suggested that the primary pathway for BPA exposure is food, and data on the pharmacokinetics of BPA indicate rapid elimination in urine. Stahlhut et al. (2009) did not find the expected relationships, however. Instead, they found little consistent pattern in the change of BPA concentrations in urine as a function of fasting time. The authors suggested that, whereas other information supported a conclusion that the dietary pathway predominated as a source of BPA, the NHANES results may instead have been influenced by other exposure pathways.
This study examines patterns of urinary DEHP metabolites with age, and reported fasting time in the 2007-2008 NHANES data set, the most recent available, in the context of known pharmacokinetic data for DEHP metabolism and elimination. The primary goal of the analysis is to evaluate whether the relationships between urinary DEHP metabolites and food fasting time in the NHANES data set support the conclusion that diet is the predominant pathway for exposure to DEHP in the general United States population. Additional factors affecting the interpretation of the NHANES data on urinary DEHP metabolites are also examined. These factors include age and associated variables, NHANES session of examination (morning, afternoon, and evening), and time since last urinary void. Finally, pharmacokinetic factors impacting the accuracy of estimated intake doses of DEHP based on spot urine samples and application of urinary excretion fractions for DEHP metabolites are examined.
Methods
Data collected through the National Health and Nutrition Examination Survey (NHANES) were used in these analyses. NHANES, conducted by the CDC National Center for Health Statistics, employs a complex, stratified, multistage sampling of the civilian, non-institutionalized United States population, and includes laboratory examination and questionnaire components. Since 1999, the survey has been conducted on a continuous basis, with approximately 5000 individuals included each year, and data are reported in 2-year cycles. Urine specimens from a subsample of NHANES participants have been analyzed for metabolites of a growing list of phthalate ester metabolites, including metabolites of DEHP. Results from these analyses are available for four NHANES cycles (2001-2002 through 2007-2008 cycles) . Data sets from the 2007-2008 cycle were downloaded from the NHANES web site, http://www.cdc. gov/nchs/nhanes.htm. All statistical analyses were conducted using STATA IC10 (StataCorp LP, College Station, TX, USA).
Percentiles of DEHP Metabolites and Distribution of Fasting Times, NHANES 2007-2008
Selected key population-weighted percentiles of the four DEHP urinary metabolites measured during the 2007-2008 NHANES cycle were estimated on the basis of creatininecorrected DEHP metabolite concentrations rather than volume-based concentrations, as data suggest that creatinine correction can reduce the impact of variations in hydration status on the measured urinary concentrations (Preau et al., 2010) .
The time since the last reported food consumption was calculated for each participant, with urinary phthalate metabolite measurements as a sum of the reported hours and minutes since last food consumption (variables phafsthr þ phafstmn/60). These hour and minute variables were determined with the simple question, ''When was the last time you ate or drank anything other than plain water?''
The distribution of the reported time since last food consumption, using the appropriate population subsample weights, was plotted for all participants with measured urinary DEHP metabolites from the NHANES 2007-2008 cycle.
Evaluation of Trends in Urinary Metabolite Concentrations with Reported Fasting Time and Other Covariates
Urinary DEHP metabolite kinetics in an adult male volunteer following controlled dosing have previously been reported by Koch et al. (2005) . We examined the urinary concentration time course data from Koch et al. (2005) to select time periods following last reported food intake for examination of potential trends, with fasting time for DEHP metabolites in the NHANES dataset from 2007 to 2008, to evaluate the consistency of these data with the hypothesis that DEHP exposure occurs primarily through dietary exposure. We conducted linear regressions between the lntransformed concentrations of DEHP metabolites and independent variables of food fasting time, age, and urinary creatinine concentration, using command ''regress'' in STATA, except for mono-2-ethylhexyl phthalate (MEHP), for which we conducted a censored normal regression (command ''cnreg'') due to a significant proportion of nondetectable concentrations in the dataset. We explored entry of urinary creatinine concentration as an independent variable in the regressions because of the possibility that urinary creatinine concentration may be independently correlated with the other covariates of interest (Barr et al., 2005) , as well as conducting the regressions on creatinine-corrected concentrations. We also examined these relationships when results were stratified by session of examination (morning, afternoon, or evening), and age. We applied the appropriate subsample weights in all analyses, to increase the ability to generalize the results of these analyses.
Session of Examination and Metabolite Ratios
Although exposure to DEHP may occur primarily through diet, unless DEHP is uniformly present in diet, there is unlikely to be a perfect correlation between time since last food ingestion, and time since last detectable DEHP exposure. In addition, recall of time of last food ingestion may be imperfect, leading to uncertainty in this parameter. Lorber et al. (2010b) proposed evaluation of the ratio between the concentrations of two key DEHP metabolites (mono-(2-ethyl-5-carboxypentyl)phthalate (MECPP) and mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP)) as a means for characterizing the relative length of time since last detectable DEHP exposure among samples. We evaluated the distribution of this ratio in the NHANES 2007-2008 samples, and evaluated the trend with reported food fasting time. We also examined the concentrations of metabolites as a function of session of examination (morning, afternoon, or evening) to assess whether later-day samples might capture increasingly substantial DEHP exposures over the course of the day, compared with early-day samples.
Factors for Consideration in Variations in Urine Concentrations and Use of NHANES Data to Estimate Intake Doses
Estimates of the fraction of administered dose of DEHP excreted in urine as each metabolite (urinary excretion fractions, or F UE ) are available from Koch et al. (2005) . Urinary excretion fractions have been used in a creatininecorrection approach to back-calculate the estimated intake dose by several authors (Calafat and McKee, 2006; Fromme et al., 2007; Wittassek et al., 2011) . We conducted several simulations using the Lorber et al. (2010a) pharmacokinetic model for DEHP, to evaluate the impact of fasting time and variations in time since last urinary void before the NHANES sample collection void, to evaluate the potential variability in urine concentrations based on time of last void. In addition, we used these simulations to comment on the theoretical accuracy of the estimated intake doses derived from spot urinary creatinine-corrected concentrations and urinary excretion fractions derived from Koch et al. (2005) .
Results and discussion

Description of Urinary DEHP Metabolite Concentrations and Reported Fasting Times
Key percentiles for urinary DEHP metabolite concentrations in the 2007-2008 NHANES dataset are presented in Table 1 . The distribution of reported fasting time is bimodal (Figure 1 ), reflecting the difference in fasting instructions given to morning vs afternoon, or evening participants. Longer fasting times (48 h) are predominantly reported by participants examined in the morning session. Participants with morning appointments older than age 12 were requested to fast, beginning at 2300 h the previous night, and many Summed measure of each of the four metabolites by individual, with non-detects replaced by LOD/sqrt(2). LODs were: MEHP ¼ 1.1 ng/ml; MEHHP ¼ 0.7 ng/ml; MEOHP ¼ 0.6 ng/ml; MECPP ¼ 0.5 ng/ml.
reported doing so. Participants in afternoon and evening sessions were not directed to fast, and reported fasting times reflect typical times since the previous meal the same day (breakfast or lunch for afternoon session participants, and lunch or dinner for evening session participants). Note that these fasting instructions differ from those given during the NHANES 2001-2002 and 2003-2004 cycles, in which all participants older than age 12 were requested to fast, regardless of session of examination (no food after 2300 h, 0730 h, and 1100 h for morning, afternoon, and evening participants, respectively). Participants under age 12 were not instructed to fast during any NHANES cycle.
Regression Analyses
We explored a variety of covariates in our analysis of potential relationships between urinary DEHP metabolites and food fasting time. Figure 2 shows the trends of MEHHP concentration with age, based on a fractional polynomial fit to the dataset. Because of the relatively steeper apparent relationship with age in persons under age 18, we stratified our regression analyses on age ( r18 and 418 yrs). We also examined gender, body mass index, and reported race/ ethnicity as potential covariates, but omitted them from final models due to few and inconsistent relationships observed (data not shown). We examined the urinary excretion time course following controlled dosing with D4-labeled DEHP in Koch et al. (2005) , to inform our selection of fasting times for regression analysis for trends with fasting time. In the Koch et al. (2005) experiment, a male, aged 61 years and weighing 75 kg, selfdosed with 48.5 mg of DEHP, mixed with butter in buttered toast. This dose, 650 mg/kg, is substantially higher than typical background exposures, which are estimated to be in the range of 1-10 mg/kg/day (Lorber et al., 2010a; Clark et al., 2011; Wittassek et al., 2011) . Data taken from this individual included four samples of blood during the first 8 h and 24 urine samples during the 44 h following exposure. Trend of mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP) with age. Fitted line and confidence intervals generated with a fractional polynomial fit to the data. Based on a visual assessment of the relationships observed with age, we stratified subsequent analyses by age (r18 years, 418 years). Table 2 for the results of the regression analyses. Figure 1 . Histograms of reported food fasting times in hours for National Health and Nutritional Examination Survey (NHANES) participants with measured urinary di(2-ethylhexyl) phthalate (DEHP) metabolites by session of participation. Participants older than age 12 in the morning session were requested to abstain from food consumption after 2300 h the previous evening, whereas afternoon and evening participants were not instructed to fast. Thirteen participants reported fasting times greater than 24 h (omitted from these graphs).
urinary concentrations of the three longer-lived metabolites (MEHHP, mono-(2-ethyl-5-oxohexyl)phthalate (MEOHP), and MECPP), with a plateau and gradual beginning of decreasing concentrations over the first 6 h. This time course reflects the kinetics of gastrointestinal absorption and distribution of DEHP with rapid metabolism to MEHP, followed by conversion to the secondary metabolites and elimination from circulation into the bladder. From 6 to approximately 18 h following dosing, urinary concentrations declined fairly steadily. For times more than 18 h from exposure, the measured urinary metabolite concentrations in Koch et al. (2005) experiment were low and variable, consistent with other possible sources of variation such as variations in hydration status, delayed metabolism, analytical variation, and so on, becoming relatively more influential. On the basis of this observation, we conducted regression analyses between DEHP metabolites and fasting time during two periods of reported fasting times: r6 h, and 46 h to r18 h. As discussed above, we stratified the analyses on age and retained age as a covariate in the models.
The regression results differed substantially by age ( Table 2) . Influence of food fasting time was clearly apparent for participants older than age 18 for the period of 6 to 18 h of fasting time. In contrast, for participants younger than 18, the relationships with fasting time were similar in direction, but were non-significant for all metabolites, both at early periods (fasting time r6 h) and at longer fasting times. A substantial and significant effect of age on measured metabolite concentrations was noted for participants younger than age 18, for nearly all combinations of fasting time and metabolite (Table 2) , with age negatively correlated with DEHP metabolite concentrations. Slight and sometimes significant relationships with age were present in participants older than 18 for some metabolites, but the magnitude of the relationship was much smaller (consistent with Figure 2) . Although significant relationships with fasting time and age were observed, substantial variability in the data not explained by the regression covariates remains. Figure 3 demonstrates the variability in the data and the observed regression relationships between MEHHP and fasting time for participants 418 yrs of age. Regression results using creatinine-corrected metabolite concentrations as the outcome variable (with age and food fasting time as independent covariates) were very similar in pattern, magnitude, and statistical significance. However, consistent with other studies, the models explained a lower proportion of the variability in the data when creatinine-correction was used, instead of including creatinine as an independent covariate in the regression (Preau et al., 2010) .
The relationship between DEHP metabolite concentrations in urine and reported fasting time in adults in the NHANES 2007-2008 dataset is consistent with previous evaluations, which suggest that the primary route of exposure to DEHP is via dietary sources. Urinary DEHP metabolite concentrations tended to decrease with increasing fasting times for fasting times greater than 6, and less than 18 h, consistent with the data from a controlled dosing experiment discussed earlier (Koch et al., 2005) , including a similar approximate rank order of metabolite concentrations. Detailed examination of the data within that range of fasting times shows that the trends in metabolite concentrations flatten out for fasting times between 14 and 18 h. This could be a consequence of sparser data in this range of fasting times, greater imprecision in longer reported fasting times, greater relative magnitude of other sources of variability such as analytical imprecision, a combination of these factors, or other factors. For example, Stahlhut et al. (2009) , in their analysis of BPA trends with fasting times in NHANES, suggested that such patterns might suggest evidence of some storage of compound in fatty tissues with slower re-release that becomes apparent at longer time periods. However, no pharmacokinetic data are currently available to support retention of parent DEHP or its metabolites in fatty tissues, or other depots in the body, and additional experimental work would likely be required to examine this issue further. Figure 4 shows the regression lines for the regression results for 6 to 18 h of fasting time for adults for the four metabolites. The coefficients from the regression on ln-transformed values allow direct calculation of an ''apparent'' first-order urinary elimination half-life from the population sampling data. These regression coefficients and calculated apparent half-lives from the adult data for fasting times between 6 and 18 h are shown in Table 3 , and Figure 4 . Regression fits and confidence intervals for four di(2-ethylhexyl)phthalate (DEHP) metabolites for participants 418 years of age, and fasting times from 6 to 18 h. The results are consistent with the results of controlled-dosing studies by Koch et al. (2005) , in which concentrations of mono-(2-ethyl-5-carboxypentyl)phthalate (MECCP) and mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP) were similar, with somewhat lower concentrations of mono-(2-ethyl-5-oxohexyl)phthalate (MEOHP), and the lowest concentrations of mono-2-ethylhexyl phthalate (MEHP). Apparent half-lives for urinary elimination based on these regressions are presented in Table 3 , and compared with the experimental half-lives from the Koch et al. (2005) experiment. agree well with the experimental half-lives estimated from the controlled dosing experiment. The patterns shown in Figure 4 and the calculated half-lives from these regressions, which are similar to experimentally derived half-lives, provide compelling evidence for the importance of diet and DEHP exposure.
Analysis of Fasting Times Less Than 6 h
Interpretation of shorter fasting times, that is, fasting times less than 6 h, was confounded by differences in fasting patterns among NHANES 2007-2008 participants. As noted earlier, it was only the individuals from the morning sample who were instructed, and who did, fast before the sampling time. For the analysis of data between 6 and 18 h fasting described above, there were a total of 916 data points, of which 796 originated from the morning sample. The afternoon and evening samples were dominated by individuals who reported last food consumption within about 8 h. Figure 5 shows a scatter plot of MEHP creatininecorrected concentrations in adults for the three sampling sessions, and best-fit correlation lines within the scatter as a function of reported fasting times. Persons providing a sample in the evening tended to have higher urinary concentrations of MEHP as compared with those providing an afternoon or a morning sample. Although the data are highly variable, a comparison of estimates of central tendency across sessions demonstrates this difference. For the evening sample, the average concentration for fasting times r6 h (which encompassed 84% of the samples) was 11.5 mg/g creatinine (median ¼ 3.5 mg/g creatinine). For the afternoon sample, the average for fasting times r6 h Urinary creatinine concentration was included in the model as an independent covariate, and was a significant predictor in all regression models (coefficients not reported here). Statistically significant results (Po0.05) are bolded. Table 3 . Apparent half-lives for urinary elimination based on regression results from fasting times between 6 and 18 h for participants 418 years of age (see Table 2 ) compared with experimental half-lives from controlled dosing in Koch et al. (2005 (86% of samples) was 7.9 mg/g creatinine (median ¼ 2.4 mg/g creatinine). For the morning sample, the average for fasting times r6 h (10% of samples) was 6.5 mg/g creatinine (median ¼ 2.6 mg/g creatinine).
These trends F similarity in the morning and afternoon samples, which are both lower than the evening sample F also can be considered to support the hypothesis that diet drives exposures to DEHP, as evening participants may have had the opportunity for more substantial food consumption, and more substantial meals (lunch and dinner) within the hours before examination, compared with participants in sessions earlier in the day, even for the same reported fasting times.
The difference between the evening samples and other samples is further evaluated by examining the relationships among the metabolites. Up until this point in this analysis, reported fasting time has been used as a surrogate for time since last exposure to DEHP, as exposure to DEHP has been hypothesized to occur largely through diet. But as noted above, DEHP is unlikely to be uniformly distributed in all foods, so time since last food consumption is likely to be an imperfect surrogate for time since last detectable exposure to DEHP. Lorber et al. (2010b) analyzed the ratio of the concentration of the tertiary metabolite, MECPP, to the secondary metabolite, MEHHP as a way of shedding light on when the last exposure occurred. This order-oriented terminology reflects the fact that, while both MEHHP and MECPP form downstream of MEHP via parallel paths, MEHHP is believed to form directly from MEHP, whereas formation of MECPP requires multiple metabolic reactions (Albro et al., 1982; Koch et al., 2005) . Available data from Koch et al. (2005) experiment indicates that the elimination of MECPP has a longer urinary elimination half-life than MEHHP (12 to 15 h vs approximately 10 h). Analyses of available datasets by Lorber et al. (2010b) indicated that shortly after exposure, the concentrations of these two metabolites are similar, and the ratio is close to 1.0. They showed that, given no further exposures, the concentration of the MECPP will eventually dominate the profile of DEHP metabolites in urine, and the ratio of MECPP to MEHHP will be greater than 1.0. With no exposure for about 16 h or more, the ratio would exceed 1.5. They analyzed data from experiments on two individuals whose exposures were elevated and known, and confirmed that the ratio increased with increasing time since exposure, although the magnitude of the ratios varied between these two individuals. Lorber et al. (2010b) proposed evaluation of that ratio in NHANES as a marker for time since last significant DEHP exposure. For this study, we looked at this key ratio in urine as a function of fasting time over the period from 0 to 24 h, or reported time since last food consumption. Figure 6 shows the scatter in this ratio over the entire data set, and superimposed on the scatter plot are best-fit regression lines for the adult evening session only (n ¼ 292), and for adults sampled in the morning and afternoon sessions combined (n ¼ 1551). There is a steeper positive slope for evening participants, 0.051 vs 0.022, suggesting the ratio increases more steeply with increasing hours since last food consumption for this cohort, and the intercept for the evening participants, 1.3 vs 1.5, is closer to the experimentally observed ratio of approximately 1, immediately following exposure. This pattern of results further supports the hypothesis, provided above, that for the evening session participants, reported food fasting time is a better surrogate for time since last detectable exposure than in the morning and afternoon sessions, and evening participants are more likely to have been recently exposed to DEHP due to dietary exposures.
Analysis of a Key Confounder: Time Since Last Urinary Void
Although the 6-18 h fasting data demonstrate general trends consistent with those predicted from the controlled-dosing experiment data (Koch et al., 2005) , the data still show substantial scatter. Although variations in metabolite concentrations will be influenced by magnitude of exposure, additional factors would be expected to contribute to the observed variability. One such factor is time since last urinary Figure 5 . Relationship between mono-2-ethylhexyl phthalate (MEHP) and fasting time for participants ages 418 stratified by session. Solid lines are the censored normal regression best fits and dotted lines encompass ± 1.96 SD of the fitted linear relationship. The number of participants included is 825, 620, and 285 for the morning, afternoon, and evening sessions, respectively. void before sampling. Although information is available on time of last food consumption (and hence possible dietary exposure), information is not available on the time of last void. This can be an important source of variability, given that DEHP metabolite half-lives are on the order of hours. For example, if exposure to DEHP occurred 5 h before sampling (approximately 1 half-life for urinary elimination of MEHP), and an individual voided 1 h before the sample collection void, about half of the ultimate excretion of MEHP was likely excreted in the earlier void. However, if the individual had not voided since that exposure 5 h earlier, it is likely that concentrations and mass excretion of MEHP would be higher and more informative about the recent exposure.
The potential impact of this variability was studied with a simple pharmacokinetic model, which can predict urinary concentrations of DEHP metabolites, given defined times of intake and defined urine events (Lorber et al., 2010a) . Figure 7 presents a series of predicted concentration profiles for MEHHP in urine estimated using this model. The simulations assume a constant rate of urine production at a rate of 1.7 l/day for a 75 kg individual, and track predicted concentrations in urine following a 0.01 mg/kg dose (occurring at time 0 h on the graph). The theoretical curve represents a conceptual concentration profile that would be expected, if continuous aliquots of urine were collected and analyzed, and is a model of the instantaneous excretion rate of MEHHP following this dosing profile. Because the urinary bladder acts as a holding reservoir, the concentration in urine at any time point is a time-weighted average of the instantaneous concentrations from the theoretical curve since the previous void. Other curves on Figure 7 show theoretical concentrations that would result if the daily 1.7 l of urine are parsed over 2, 4, and 6-hr periods. Note that the deviation from the theoretical concentration curve is not a ''random'' bias for any time period greater than about 4 h after exposure; increasing time since previous urinary void translates to higher measured concentrations than predicted theoretically.
The 24-h average concentration over this time period is reflected by the thick horizontal dotted line. The theoretical curve is equal to the 24-h average, at approximately 8 h post exposure. However, at that time point, predicted concentrations assuming voids at 2, 4, and 6 h before the sampling event are 0.08, 0.13 and 0.20 mg/l, respectively. That suggests a variation of 2.5-fold in predicted concentration of MEHHP for spot samples taken 8 h following last exposure based solely on variations in urinary void timing. The range is even higher for MEHP, which is metabolized more rapidly than MEHHP.
Comment on the Use of NHANES 2007-2008 to Infer Intakes Using the Creatinine Correction Approach and Urinary Excretion Fractions
The results in Figure 7 also are informative with regard to use of NHANES (and similar surveys) to infer intake rates, using a creatinine-correction or a urine volume-correction Figure 7 . Predicted concentration profiles for mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP) in urine, estimated using the Lorber et al. (2010a) di(2-ethylhexyl)phthalate (DEHP) pharmacokinetic model. The simulations assume a constant rate of urine production at a rate of 1.7 l/day for a 75 kg individual, and track predicted concentrations in urine following a 0.01 mg/kg dose at time 0 h on the graph. The theoretical curve represents a conceptual concentration profile that would be expected if continuous aliquots of urine were collected and analyzed, and is a model of the instantaneous excretion rate of MEHHP following this dosing profile. Because the urinary bladder acts as a holding reservoir, the concentration in urine at any time point is a time-weighted average of the instantaneous concentrations from the theoretical curve since the previous void. Other curves on Figure 6 show theoretical concentrations that would result if the daily 1.7 l of urine assuming urinary voids with 2, 4, and 6-h periods. approach, and application of experimentally derived urinary excretion fraction. The premise behind the use of these 24-h mass-balance approaches is that the concentration of a metabolite in a given spot sample is representative of the daily average urinary concentration resulting from a given DEHP exposure. As suggested by Figure 7 , samples collected before approximately 8 h following exposure would contain concentrations higher than the daily average urinary concentration. Thus, intake estimates calculated from spot samples taken within approximately 8 h of exposure would overestimate actual intake dose, whereas those collected more than 8 h following exposure would tend to underestimate intake dose according to the theoretical excretion curve. Longer time since last urinary void would tend to extend these time frames, with longer times since last exposure, required to obtain a sample with concentration representative of the 24 h average concentration.
Therefore, if a survey comprised of individuals providing only a morning fasting sample, one might expect to generally underestimate the daily intake of DEHP if they fasted, starting at 2300 h the previous evening. However, a different expectation would emerge if the survey results were collected throughout the day, without any instructions to fast, as were the afternoon and evening samples of NHANES 2007-2008. With recent exposure, the tendency instead might be to overestimate intake dose.
The potential degree of over-or underestimation is in the range of up to approximately four-fold in either direction. That is, at short time since last exposure (2 to 4 h), estimated intakes based on spot sample concentrations may be overestimated by up to approximately four-fold. At long time since last exposure (414 h), the actual intakes may be underestimated by up to four-fold. On the basis of the cumulative distribution of reported fasting times in the 2007-2008 NHANES sample, the 50 th percentile of reported fasting times was approximately 8 h. Approximately 40% of participants (those in the afternoon and evening samplings, primarily) reported fasting times less than 4 h, whereas only 10% reported fasting times longer than 14 h. Thus, the estimation of intake rates based on application of the urinary excretion fraction estimates to the measured concentrations in NHANES 2007-2008 spot samples, which may be more likely to over-than underestimate actual exposures to DEHP, assuming fasting time is an appropriate surrogate for time since last exposure. Application of a simple quantitative adjustment for reported fasting time to estimate intake dose based on a spot urine sample concentration is likely to be problematic, given the non-monotonic nature of the relationship between urinary concentrations and fasting times within the first 6 h, following exposure observed in the controlled-dosing data and in the NHANES dataset, and the lack of other relevant information such as oral absorption rate, individual metabolic rates, and time since last urinary void.
Comment on Children's Exposure
The analyses here have focused primarily on adults. Patterns observed in participants under age 18 with fasting time were similar in direction, but non-significant. In this age group, concentrations were strongly and inversely correlated with age. This may be in part due to the use of creatinine-adjusted values in the analysis. Creatinine excretion per unit bodyweight increases substantially with increasing age in children (Remer et al., 2002) . This suggests that, for the same daily dose on a bodyweight basis and urinary excretion fraction, the creatinine-adjusted metabolite concentration will be higher in younger children than in older children. In addition, because children aged 6 years consume more than twice as much food per kg bodyweight per day than persons aged 18 years (EPA, 2008) , intake and thus excretion of compounds for which diet is the primary route of exposure will be substantially higher in younger children on a per kg bodyweight basis. These two factors alone would predict a strong inverse association between urinary concentrations and age in children aged 6 to 18 years, consistent with the trends observed in the NHANES samples in this analysis (see Table 2 and Figure 2 ).
Conclusions
The concentrations of urinary DEHP metabolites in the NHANES 2007-2008 data set vary widely, with 95 th percentile concentrations nearly 10 times higher than median concentrations. The initial impression based on such data is that this variability reflects variation in exposure rates. However, the analyses here point to several substantial sources of variability in addition to variations in exposure rates, including variations in time since last exposure, variations in time of day of sampling, variations in time of last urinary void, and variations in creatinine excretion rates used for normalization of hydration status (for unnormalized evaluations). Other potential sources of variation include potential inter-individual variability in metabolic patterns or rates, for which no data are available to evaluate. Many of these sources contribute to within-day, within-individual variability in spot urinary concentrations that may be greater than the across-individual variation in absolute exposure rate (Preau et al., 2010) . Thus, interpretation of the extremes of urinary concentrations in population-based data sets for transient compounds such as the phthalates must be made cautiously.
Estimates of intake rates of phthalates derived from urinary concentration data have been made, using a simple mass-balance equation that takes into account 24-h metabolite urinary excretion fraction, relative molecular weights of parent and metabolites, and estimates of 24-h urinary creatinine excretion or volume (Kohn et al., 2000; Calafat and McKee, 2006; Koch et al., 2007) . This approach depends on an assumption that spot sample concentrations are an adequate surrogate for 24-h average urinary concentrations. The sources of variability described above, as well as other available data and analyses (Aylward et al., 2009; Lorber et al., 2010a; Preau et al., 2010) , demonstrate that spot sample concentrations reported in NHANES are likely to vary from the 24-h urinary average concentration for an individual due to variations in time since exposure, time since last urinary void, individual variation in the kinetics of absorption, metabolism, and elimination, and other factors. An estimate of intake for an individual based on his/her spot sample concentration will likely over-or underestimate actual intake on the day the sample was taken, and does not provide information regarding potential acrossday variation in intake rates for that individual, which may also be substantial (Preau et al., 2010) . The analyses presented here can assist in quantification of the uncertainties and possible biases in intake estimates derived from population spot sample data sets such as NHANES.
The analyses in this study do support the hypothesis that the primary route of DEHP exposure is dietary. Evidence presented here includes trends in urinary excretions of DEHP metabolites as a function of reported food fasting time consistent with those observed in controlled-dosing experiments, and patterns seen in evening samples F alone and in comparison with samples taken in the morning and afternoon F which are consistent with expectations if diet is the primary route of DEHP exposure. Similar analyses of NHANES data sets for metabolites of other phthalate compounds should be undertaken. Such analyses can inform evaluation of the relative importance of diet as a pathway for exposure to these compounds in the United States, information, which may be useful in risk assessment and risk management efforts.
